Tempest Therapeutics, Inc. — Director's Dealing 2012

Jun 11, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2012-06-11

Reporting Person: BLECK CHRISTOPHER A (VP and COO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$.0405	2021-12-06	Common Stock (112703)		Direct

Footnotes

F1: This option will become exercisable ("vest") as to 25% of the original number of Shares on the first anniversary of the Vesting Commencement Date (as defined) and as to an additional 6.25% of the original number of Shares at the end of each successive quarter following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date. For purposes of this option grant, "Vesting Commencement Date" shall mean November 14, 2011.